logo

 

MIRA INFORM REPORT

 

 

Report Date :

14.04.2011

 

IDENTIFICATION DETAILS

 

Name :

SRI BIOTECH LABORATORIES INDIA LIMITED

 

 

Formerly Known As :

SRI BIOTECH INDIA PRIVATE LIMITED

 

 

Registered Office :

“Biosphere”, Plot No.21, Sagar Society, M.H. No.8-2-269/5/21, Road No.2, Banjara Hills, Hyderabad – 500 034, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

13.10.2006

 

 

Com. Reg. No.:

01-050060

 

 

CIN No.:

[Company Identification No.]

U24239AP2006PLC050060

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS18479G

 

 

PAN No.:

[Permanent Account No.]

AAKCS6296B

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Trader of Agricultural Fertilizer and Pesticides.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (51)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 4139000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having fine track. General financial position of the company is good. Trade relations are fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Ms. Sarita

Designation :

HR Department

Date :

08.04.2011

 

 

LOCATIONS

 

Registered/ Corporate Office/ Factory 1 :

“Biosphere”, Plot No.21, Sagar Society, M.H. No.8-2-269/5/21, Road No.2, Banjara Hills, Hyderabad – 500 034, Andhra Pradesh, India 

Tel. No.:

91-40-64642789/ 32580685/ 23701153

Fax No.:

91-40-23702823

E-Mail :

ramesh@sribio.com

infosribio@gmail.com

sribio@gmail.com

vvmsrao@sribio.com

Website :

www.sribio.com

Location :

Owned

 

 

Factory 2 :

Plot No.1-3, 16-18, Phase-Il, Pashamylaram, Patancheru-Mandal, Medak District, Andhra Pradesh, India

 

 

Factory 3 :

SY No.195, 196, Komepadu Village, Vatticherukuru-Mand, Guntur-District, Andhra Pradesh, India

 

 

Branch Office :

8-3-166/6 and 7, Flat No.211, Bhavya’s Sree Arcade, Erragadda, Hyderabad – 560 018, Andhra Pradesh, India

 

 

R and D Centers :

Pashamylaram, Nadigama, Tangutur, Guntur, Kurnool and Ballery

 

 

DIRECTORS

 

As on 30.09.2009

 

Name :

Dr. Kondamadugula Ramakoti Reddy

Designation :

Chairman and Managing Director

Address :

8-3-315/9/A, Plot No.24, Maruthi Nagar, Yousufguda, Hyderabad, Andhra Pradesh, India

Date of Birth/Age :

15.07.1967

Date of Appointment :

13.10.2006

DIN No.:

00259576

 

 

Name :

Ms. Anuradha Konda Madugula

Designation :

Director

Address :

8-3-315/9/A, Plot No.24, Maruthi Nagar, Yousufguda, Hyderabad, Andhra Pradesh, India

Date of Birth/Age :

02.06.1968

Date of Appointment :

13.10.2006

DIN No.:

02128286

 

 

Name :

Annapa Reddy Prakash Reddy

Designation :

Whole-Time Director

Address :

Plot No.33, Siddartha Nagar, Near A.G.S. Colony, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

15.03.1959

Date of Appointment :

12.08.2009

DIN No.:

02592019

 

 

Name :

Dr. Vijay Dilbagh Rai

Designation :

Director

Address :

207, New Bake House, 12, MCC Lane, Fort, Mumbai – 400 001, Maharashtra, India

Date of Birth/Age :

13.10.1946

Date of Appointment :

26.03.2009

DIN No.:

00075837

 

 

Name :

Mr. Rajesh Kumar Srivastava

Designation :

Director

Address :

S-376, Ground Floor, Panchshila Park, New Delhi – 110 017, India

Date of Birth/Age :

20.03.1957

Date of Appointment :

02.03.2009

DIN No.:

00302223

 

 

Name :

Mr. Suneet Gupta

Designation :

Director

Address :

A-44, Second Floor, Defence Colony, New Delhi – 110 024, India

Date of Birth/Age :

20.02.1970

Date of Appointment :

02.03.2009

DIN No.:

01653720

 

 

Name :

Professor Bir Bahadur

Designation :

Director

Address :

The Odyssey-4A, 10-2-289/46, Shanthinagar, Masab Tank, Hyderabad – 500 028, Andhra Pradesh, India

Date of Birth/Age :

05.04.1938

Date of Appointment :

24.03.2008

DIN No.:

02130067

 

 

Name :

Dr. Yemmiganur Ramalinga Sarma

Designation :

Director

Address :

M10-5,

Date of Birth/Age :

12.05.1942

Date of Appointment :

24.03.2008

DIN No.:

02130792

 

 

Name :

Ms. Annapa Reddy Padma Sireesha

Designation :

Director

Address :

Plot No.33, Siddartha Nagar, Near A.G. Colony, Hyderabad, Andhra Pradesh, India

Date of Birth/Age :

15.07.1965

Date of Appointment :

24.03.2008

DIN No.:

02143924

 

 

Name :

Mr. Utpal Sen Gupta

Designation :

Director

Address :

P-411, G Block, Ground Floor, New Alipore, Kolkatta – 700 053, West Bengal, India

Date of Birth/Age :

05.10.1949

Date of Appointment :

26.03.2009

DIN No.:

02577237

 

 

Name :

Gottumukkala Lakshmi Narasimharao

Designation :

Director

Address :

H.No.8-3-315/9/A, Plot No.24, Maruthi Nagar, Yousufguda, Hyderabad, Andhra Pradesh, India

Date of Birth/Age :

22.02.1941

Date of Appointment :

16.07.2008

Date of Ceasing :

26.03.2009

DIN No.:

02296941

 

 

Name :

Mr. Koteshwar Bommakanti

Designation :

Director

Address :

16-10-1433, Shivanagar, Warangal – 506 002, Andhra Pradesh, India

Date of Birth/Age :

09.11.1961

Date of Appointment :

16.07.2008

Date of Ceasing :

26.03.2009

DIN No.:

02270978

 

 

Name :

Mr. Prabhu Chendurpandan

Designation :

Alternate Director

Address :

B-11, Kakateeya Apartments, Plot No.86, Patparganj, IP Extension, New Delhi – 110 092, India

Date of Birth/Age :

01.06.1973

Date of Ceasing :

12.11.2010 

DIN No.:

02179583

 

 

KEY EXECUTIVES

 

Name :

Ms. Sarita

Designation :

HR Department

 

 

Name :

Tamada Kamala Kumari

Designation :

Company Secretary

Address :

16-1-472, Saidabad, Hyderabad, Andhra Pradesh, India

Date of Birth/Age :

27.05.1980

Date of Appointment :

16.07.2008

PAN No.:

AHQPT5498L

 

 

Name :

Sharath Chandra Kusumba

Designation :

Company Secretary

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2009

 

Names of Shareholders (Equity Shares)

 

 

No. of Shares

K.R.K. Reddy

 

4442224

K. Anuradha

 

5043349

A. Padma Siressha

 

26250

K. Rami Reddy

 

26250

K. Ramanamma

 

26250

G. Santha Kumari

 

26250

A. Rahul Reddy

 

26250

J. Divakar

 

29938

A.J. Forsyth

 

21065

Vinuthna Reddy

 

113900

Sri Varshitha Reddy

 

129320

Total

 

9911046

 

Names of Shareholders (Preference Shares)

 

 

No. of Shares

India Agri Business Fund Limited, Mauritius

 

22421250

Real Trust, India

 

78750

Total

 

22500000

 

As on 13.11.2009

 

Names of Allottees (Equity Shares)

 

 

No. of Shares

India Agri Business Fund Limited, Mauritius

 

4750769

Real Trust, India

 

16686

Total

 

4767455

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Trader of Agricultural Fertilizer and Pesticides.

 

 

Products :

  • Biofertilizers
  • Biopesticides
  • Biocontrol Agents
  • Seaweed Liquid Fertilizers
  • Organic Manures
  • Plant Growth Stimulants
  • Herbal Based Fungicides and Insecticides
  • Bio Herbicide
  • Repellants and Probiotics
  • Bioremediates

 

 

Terms :

 

Selling :

Depend

 

 

Purchasing :

Depend 

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers and Research Institutions

 

 

No. of Employees :

387 (Approximately)

 

 

Bankers :

  • Yes Bank Limited, 9th Floor, Nehru Centre, Discovery of India, Dr. Annie Besant Road, Worli, Mumbai – 400 018, Maharashtra, India 
  • Axis Bank
  • Punjab National Bank
  • Allahabad Bank
  • State Bank of Hyderabad

 

 

Facilities :

Secured Loans

31.03.2010

Rs. In Millions

31.03.2009

Rs. In Millions

From Banks

Term Loan

(Secured by hypothecation of fertilizer unit under NABARD, existing and future machinery and equitable mortgage of corporate office).

[amount repayable within one year Rs.0.906 million (previous year: Rs.0.503 million)]

3.722

4.225

From Others

Term baa from Technology Development Board

(Secured by hypothecation of movable and immovable property of the project and by personal guarantee of Directors, Dr. KRK Reddy and Anurudha Reddy. One of the Directors has pledged 250000 equity shares of Rs.10 each of the Company in favour of Technology Development Board)

37.500

11.000

Working capital loans

(Secured by hypothecation of Inventory, book debts, movable fixed assets, land, residential flats and by personal guarantee of Directors, Dr. KRK Reedy and Anuradha Reddy)

0.000

22.327

Total

41.222

37.552

 

Unsecured Loans

31.03.2010

Rs. In Millions

31.03.2009

Rs. In Millions

From Banks

[amount repayable with in one year Rs.2.238 millions (previous year: Rs.2.184 millions)]

2.833

5.017

Term loam from other than banks

[Amount repayable within one year Rs.1.193 millions (previous year: Rs.2.182 millions)]

1.193

2.182

Total

4.026

7.199

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

B.S.R. and Associates

Chartered Accountants

Address :

8-2-618/2, Reliance Humsafar, 4th Floor, Road No.11, Banjara Hills, Hyderabad – 500 034, Andhra Pradesh, India

Tel. No.:

91-40-30465000

Fax No.:

91-40-30465299

 

 

Memberships :

AP Pesticides Formulation Association and AP Seeds Association

 

 

Associates/Subsidiaries :

Sri Bio Remedies Private Limited

CIN No.: U01110AP1997PTC026890 

 

 

CAPITAL STRUCTURE

 

As on 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

15000000

Equity Shares

Rs.10/- each

Rs.150.000 millions

22500000

0.01% Cumulative Compulsorily Convertible Preference Shares

Rs.10/- each

Rs.225.000 millions

 

Total

 

Rs.375.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

14678501

Equity Shares

Rs.10/- each

Rs.146.785 millions

 

 

 

 

 

Of the above 6600000 equity shares of Rs.10/- each have been issued as fully paid bonus shares by way of capitalization of share premium account.


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

146.785

324.110

33.000

2] Share Application Money

27.101

47.028

11.892

3] Reserves & Surplus

860.758

513.031

200.513

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

1034.644

884.169

245.405

LOAN FUNDS

 

 

 

1] Secured Loans

41.222

37.552

18.763

2] Unsecured Loans

4.026

7.199

6.500

TOTAL BORROWING

45.248

44.751

25.263

DEFERRED TAX LIABILITIES

35.156

24.792

2.941

 

 

 

 

TOTAL

1115.048

953.712

273.609

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

378.437

247.393

135.298

Capital work-in-progress

93.638

63.945

19.536

 

 

 

 

INVESTMENT

9.906

9.906

22.972

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

157.569

111.491

54.931

 

Sundry Debtors

266.893

187.424

75.957

 

Cash & Bank Balances

256.977

450.793

7.590

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

64.002

41.727

11.334

Total Current Assets

745.441

791.435

149.812

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

57.889

95.540

30.523

 

Other Current Liabilities

39.597

45.279

11.542

 

Provisions

14.888

18.148

11.944

Total Current Liabilities

112.374

158.967

54.009

Net Current Assets

633.067

632.468

95.803

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

1115.048

953.712

273.609

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

757.470

655.887

415.785

 

 

Other Income

29.702

4.400

0.220

 

 

TOTAL                                     (A)

787.172

660.287

416.005

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Material Consumed

403.477

293.107

224.963

 

 

(Increase)/ Decrease in inventories of finished goods and work in progress

(23.624)

8.895

0.000

 

 

Purchase of traded goods

0.000

6.234

0.000

 

 

Personnel Costs

30.717

27.087

17.042

 

 

Manufacturing, Administrative and Selling Expenses

83.125

74.952

69.360

 

 

Research and Development Expenses

34.971

35.298

12.816

 

 

Prior Period Expenses

0.000

0.150

0.000

 

 

TOTAL                                     (B)

528.666

445.723

324.181

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

258.506

214.564

91.824

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

5.518

6.042

1.660

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

252.988

208.522

90.164

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

18.177

9.501

4.381

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

234.811

199.021

85.783

 

 

 

 

 

Less

TAX                                                                  (H)

60.190

47.380

12.886

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

174.621

151.641

72.897

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

238.067

86.426

NA

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

412.688

238.067

NA

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

2.446

--

 

TOTAL IMPORTS

NA

2.446

--

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

 

 

 

- Basic

14.89

16.13

22.09

 

- Diluted

14.54

2.95

28.90

 

Expected Sales (2010-2011): Rs.1000.000 millions

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

22.18

22.97

17.52

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

31.00

30.34

20.63

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

20.89

19.16

30.09

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.23

0.23

0.35

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.15

0.23

0.32

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

6.63

4.98

2.77

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Note:

The registered office of the company has been shifted from Flat No.211, Sree Arcade, 2nd Floor Bata Complex Erragadda, Hyderabad – 500 018, Andhra Pradesh to the present address w.e.f. 27.12.2010.

 

RESULTS OF THE OPERATIONS:

 

The seasons during the year were marked with fluctuating climatic conditions, the major agricultural areas in the country witnessed one of the worst droughts, this effected Agriculture sector adversely. Even though there was reduction in the off take of cereal crops, the Company was able to maintain a modest growth by increasing sales.

 

During the year, the company was shown a healthy performance as the sales turnover has increased to 787.172 millions as against 660.287 millions of the previous year, representing an increase of over 19.22%.

 

During the year, the Company has developed production centre and expanded the current production facility centre to meet the future targets.

 

INCREASE OF AUTHORIZED CAPITAL:

 

The Company had taken the approval for increasing the Authorized Capital from 325.000 millions to 375.000 millions and accordingly increased the Authorized Capital.

 

CONVERSION OF PREFERENCE SHARES INTO EQUITY SHARE:

 

During the year the Company has converted CCPs into full paid equity shares and in that connection issued 477,455 Equity shares of 10/- each to preference shareholders of the company.

 

OPERATIONS REVIEW:

 

The accomplishment during this endeavor is that, the Pashamvlaram Unit which is established in 2 acres of land containing R and D and Production Centre was come into full operation and started its operations.

 

Further to that they successfully inaugurated their NPK Unit situated at Guntur Plant in July month of 2010. This is establish with the production capacity of 10000000 MT per annum. This unit established for Granulated physical mixtures of NPK and Granulated micro fertilizers arid Organic manures. The revenue through this plant will be obtained in the financial year 2010-11.

 

During the year the Company has introduced three new bio-products by name GRANT, NEMOTAX and Pseudomonas Fluoresces 1% which is well received by the market.

 

During the current year the Company has penetrated its business in new states viz, Uttar Pradesh, Bihar, Gujarat, West Bengal and Chhatisgarh by setting up of network of marketing teams and these efforts will give its fruits to the revenue in the coming fiscal year, SRIBIO is on the cusp of a major expansion and diversification of its business model which will propel it into a new orbit in terms of size, diversity and performance bench marks.

 

SEED DIVISION:

 

During this year company is enormously widened its seed division by increasing its products range. Presently the total number of products under seed division are 40 as compared to the total number of products are 5 in the previous year. The revenue contributed by this division is Rs.95.300 millions which is around 10% of the total revenue of the company.

 

During this endeavor, they got a technology transfer from DRR in connection with the Improved Samba Mahsuri a novel seed variety, which is the output of their research. They are herewith authorized to multiply that seed and market the same. It is great opportunity to create a brand image in the market for their seed division.

 

EXPANSION OF MARKETING NETWORK:

 

Based on the reputation of their company in the market, the dealers’ network is increase year by year. The Company added over 910 new dealers, which also include large corporations. In result of this the total dealers under their umbrella comes to 3135 all over India.

 

The company entered in to various C and F Agreements with various agents to meet the expansion plans in the states as mentioned below;

 

·         Uttar Pradesh

·         Bihar

·         West Bengal

·         Rajasthan

 

And the Board is looking forward to establish the control system to systemize the Logistics.

 

LICENSES AND REGISTRATIONS:

 

Company has registered 10 products under Organic Certification by APEDA through VEDIC Organic Certification Agency Further to that, 12 products are registered under The Insecticides Act, 1968

 

PROJECTS:

 

The activities of the company in R and D Programs and ongoing projects under various schemes are as follows:

 

a. SBIR-Department of Biotechnology Ministry of Science and Technology. Government of India titled “Production. Formulation and Commercialization of Microbial Agents for Weed Management in Rice (Oryza Sativa L.)”

b. Technology Development Board, Ministry of Science and Technology, New Delhi-Project entitle “Novel formulation of Bio-pesticides Bio-nematicide and Plant Growth Promoting Rhizohacteria for Sustainable Crop Management”

c. Biotech Consortium of India Limited, associated with Department of Biotechnology as a part of “Biotech Industrial Training Program” (BITP, Under this scheme ever year their company creating industrial awareness to fresh Biotech graduates.

d. BIPP (Biotech Industrial Partnership Program), A collaborative Project between Sri Biotech and University of Delhi South Campus Project entitled “Development of Transinic brinjal resistant to fruit borer (Leucinodes orbanilis Gunee) through RNA interference”

 

LIQUIDITY:

 

The Company has always maintained sufficient cash to meet its strategic objectives. Liquidity in the balance sheet needs to balance between earning adequate returns and the need to cover financial and business commitments. Liquidity also enables the Company to make a rapid shift in direction, should the market so demand. During the year the internal cash accruals have adequately covered the working capital requirements and also a part of the company’s expansion plans.

 

BRANDS, TRADEMARKS:

 

The Company has allotted over 64 trademarksTM and many were granted registration.

 

PATENTS:

 

The Company got the first patent registration for outcome of its research through its Research and Development Center. The patent for which they got the registration is “Cost Effective Protocol for large scale production of Bacillus sp as Plant Growth Promoting Rhizohacteria”. Further the process of filing the application for the registration of 4 mores patents are in the process.

 

FORM 8:

 

Corporate identity number of the company

U24239AP2006PLC050060

Name of the company

SRI BIOTECH LABORATORIES INDIA LIMITED

Address of the registered office or of the principal place of  business in India of the company

Flat No.211, Sree Arcade, 2nd Floor Bata Complex Erragadda, Hyderabad – 500 018, Andhra Pradesh, India

E-Mail: sribio@gmail.com

This form is for

Modification of charge

Charge identification number of the modified 

10108930

Type of charge

Book Debts

Movable Property

Floating Charge

Others (Current Assets, Stocks, present and future)

Particular of charge holder

CIN No.: L65190MH2003PLC143249

Yes Bank Limited, 9th Floor, Nehru Centre, Discovery of India, Dr. Annie Besant Road, Worli, Mumbai – 400 018, Maharashtra, India 

E-Mail: dlbbcadsouth@yesbank.in

Nature of description of the instrument creating or modifying the charge

Supplemental Deed of Hypothecation

Date of instrument Creating the charge

27/09/2010

Amount secured by the charge

Rs.200.000 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest:

CC: 4% above YBL Base Rate (BR) i.e. 11% p.a.

WCDL: 3.5% above BR i.e. 10.5% p.a.

LC: 1.5% p.a.,   BG: 1.5% p.a.

YBL BR on 27th September 2010 is 7%p.a. YBL BR is now 7.5% p.a.

 

Terms of Repayment :

Unless Demanded earlier

Cash Credit ( CC):  Annual Review

Working Capital Demand Loan (WCDL): 60 days

Bank Guarantee: (BG): 36 months

Letter of Credit (LC): Usance: 180 days

 

Margin:

CC/WCDL:25% on  (Book debts below 90 days minus Creditors)

 

Extent and Operation of the charge:

Exclusive charge on entire current assets both present and future for INR 200.000 millions. Charge on Immovable Property already registered with the ROC in the form Memorandum of Equitable Mortgage by Deposit of title deeds as per the original deeds. 

Short particulars of the property charged

Exclusive charge on the entire current assets of the company both present and future

Date of latest modification prior to the present modification

04/05/2009

Particulars of the present modification 

Charge on the entire current assets of the company both present and future being increased from INR 50.000 millions to INR 200.000 millions. Existing charge on the Land at Survey no 147, Nandigama Village, under Nandigama gram panchayat, Patancheru Mandal, Hyderabad, Andhra (Existing Property mortgaged with them) assets remain at INR 50.000 millions.

 

TRADE REFERENCES:

 

·         IIIM – Kashmir

·         E and R Institute

 

FIXED ASSETS:

 

·         Land

·         Buildings

·         Plant and Machinery

·         Lab Equipment

·         Furniture and Fixtures

·         Vehicles

·         Computers

·         Electrical Equipments

 

WEBSITE DETAILS:

 

PROFILE:

 

• Is a hub of innovative technologies and promising products with principal domain in Agriculture, Health Care and Environmental Safety.


• Is a globally respected, multidisciplinary, biotech organization origin with its humble beginning in 1994 and taking its pursuit of noble ends to new frontiers.


• Is built on innovation and technology and creative strategies to accelerate product development.


• Comprises of strong national and international partnerships, technological tie – ups, strategic alliances working under common goals of empowering the farming community and improving human lives through safe environment.

• Is a value driven organization with its increasingly strong pipelines and product approvals that are translating and improving financial metrics and the value chain of the organization.


• Is accredited with distinguished awards and recognitions from the government of India for its hallmark performance and is well poised for an aggressive growth in the focused area of business.


• Is Knowledge-driven, customer-focused, and backed by a D and B credit rating.

 

Milestones:

 

1994

• Founded.

 

1997

• Established the first biocontrol laboratory in Andhra Pradesh.

 

2000

• Established the integrated R and D centre.

 

2001

• Installed first ever fermentation facility.

 

2003

• Recipient of AIMO’s Best Biotechnology Industry Award.

• Recognition of R and D centre by DSIR, Ministry of Science and Technology    Govt. of India.

• Secured ISO 9001:2000 certification for quality management.

 

2004

• Developed the first ever PGPR based product.

• Recipient of FAPCCI’s Best New Product Innovation Award.

• Establishment of R and D for Seed Research.

 

2005

• Recipient of National Biotech Award from Ministry of Science and Technology, Government of India.
• Recipient of AIMA National Award from President of India for creativity and Innovation.

• Recipient of “Pearl of Andhra Pradesh” Award from A. P. Government for Product launching PGPR’s.

 

2006

• Promoted “Viswas” a retail chain of one stop shops for agri inputs and    services.

• Marketing and JV tie up with Global corporate located in Kenya.

 

2007

• Product launching Sribeej brand seeds.

• MOU With NIPA Trading International, Bangladesh for marketing.

• Received award from Plant Protection Association of India.

 

2008

• Acquired land in Biotech Park Phase III (APIIC) at karakapatla.

 

Infrastructure

 

Production centre at Kukatpally, Hyderabad, A. P.:

 

SriBiotech has its owns a manufacturing unit at Kukatpally, Hyderabad with massive production capacities which is well equipped with all infrastructural facilities viz., a discovery centre especially nutritional plant, biorational and botanical extraction unit, fermentation facilities, formulation and packing units.


Integrated R and D Centre at Kukatpally, Hyderabad, A. P.:

 

SriBiotech has its owns a separate block comprising of an Integrated Research and Development centre. comprising facilities for isolation and characterization of agriculturally prominent microbes. SOP’s for solid/liquid state fermentation, Bio-efficacy studies, bioremediation studies, toxicological studies, formulation and product development.

Production Centre at Pashamylaram, Hyderabad, A.P.:

 

SriBiotech has established its own production centre in 1.55 acres at Pashamylaram, Medak District allotted by Government of Andhra Pradesh and is establishing an highly integrated production unit for manufacture of agricultural products viz. biological, organics, Micro fertilizers with production capacities of 10000 MT of powder form, 5000 KL in liquid form and 10000 MT in granule form. The aforesaid centre will be operated from financial year 2008-09.


Production Centre at karakapatla, Medak District, A.P.:


SriBiotech has acquired Land of 10 acres at karakapatla, Medak District allotted by Government of Andhra Pradesh and is establishing highly integrated Discovery Lab for research in Health Care and Environment Safety and production of therapeutics, metabolites, vector control, Phyto remediation, Residue management and waste utilization products.


Research farm at Patancheru, Ranga Reddy District, A.P.


SriBiotech has acquired Land of 8 acres at Patancheru, Ranga Reddy District and has developed a Research Farm and a Production Center for manufacture of agricultural products viz., Enriched Manures with production capacities of 30000 MT.


Seed Processing farm at Guntur District, A.P.:


SriBiotech has acquired Land of 1.5 acres in Guntur District and is establishing a Seed Processing Farm with a production capacities of 5000 MT.

 

Awards and Recognitions:

 

SRIBIO was awarded


• BS EN ISO 9001-2000 for production of Probiotics, bio–pesticides, bio- fertilizers and bio-remediation products vide Certificate Number: 18078, dated 28th June 2004 valid till 10th December 2010.


• ISO 90001:2000 for production of probiotics, bio-pesticides, bio-fertilizers and bio- remediation products vide Certificate Number: Q/0065, dated 23rd December 2006 valid till 10th September 2010.


• All India Management Association (AIMA) - GOLDEN FOUNDATION DAY AWARD for “Creativity and innovation ”received from his Excellency Dr A. P. J. Abdul Kalam, Former President of India in the year, 2006.


• “PEARL OF ANDHRA PRADESH”award from GOVERNMENT OF ANDHRA PRADESH for the year 2006.


• DSIR ( Department Of Scientific And Industrial Research, Ministry Of Science And Technology, Government Of India) NATIONAL AWARD for Research and Development efforts in Biotechnology for the year 2005 awarded by Dr. R.A. Mashelkar, Director General CSIR, Government Of India.


• “ BEST NEW PRODUCT INNOVATION” Award from Federation Of Andhra Pradesh Chambers Of Commerce And Industry (FAPCCI) for the year 2003 awarded by H.e. Dr. Y.S. Rajashekar ReddyHon’ble Chief Minister of Andhra Pradesh.


• “BEST BIOTECHNOLOGY INDUSTRIAL AWARD”from All India Manufacturers Organization (AIMO) year 2002 award by H. e. Dr. C. Rangarajan Hon’ble Government of Andhra Pradesh.


• RECOGNITION OF IN-HOUSE R and D UNIT from Government of India Ministry of Science and Technology vide Certificate Number – F. No. TU/IV- RD /2358/2005 dated 22nd March 2005 valid till 31st March 2009.

 

CREDIT RATING


• SE 2 A Performance and Credit Rating from N S I C and D and B vide D and B D-U-N-S® NUMBER 65-033-8556 indicating HIGH PERFORMANCE CAPABILITY and HIGH FINANCIAL STRENGTH.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.48

UK Pound

1

Rs.72.37

Euro

1

Rs.64.42

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

7

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

51

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.